Penumbra (PEN) Other Non Operating Income (2014 - 2023)
Penumbra (PEN) posted quarterly Other Non Operating Income of -$444000.0 for Q3 2023, up 81.15% year-over-year from -$245094.7 in Q3 2022, and down 154.95% quarter-over-quarter from $808000.0 in Q2 2023.
Penumbra (PEN) Other Non Operating Income (2014 - 2023) Analysis & Trends
Penumbra (PEN) has reported Other Non Operating Income for 10 consecutive years, with -$444000.0 the latest figure, recorded in Q3 2023.
- In Q3 2023, Other Non Operating Income rose 81.15% year-over-year to -$444000.0; the TTM figure through Sep 2023 stood at $2.4 million (up 146.75% YoY), while the FY2022 annual figure was -$2.3 million, up 40.92% from the prior year.
- Other Non Operating Income fell to -$444000.0 in Q3 2023 per PEN's latest filing, from $808000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $2.0 million in Q4 2022 and bottomed at -$2.4 million in Q3 2022.
- Historically, Other Non Operating Income has averaged -$335894.7 across 5 years, with a median of -$408000.0 in 2021.
- Annual changes were most pronounced in 2019 — Other Non Operating Income jumped 1445.45% — and 2021, when it slumped 8221.43%.
- Penumbra's Other Non Operating Income stood at $592000.0 in 2019, then surged by 32.94% to $787000.0 in 2020, then slumped by 216.65% to -$918000.0 in 2021, then soared by 317.43% to $2.0 million in 2022, then plunged by 122.24% to -$444000.0 in 2023.
- Business Quant data shows PEN's Other Non Operating Income at -$444000.0 in Q3 2023, $808000.0 in Q2 2023, and $90000.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn |
| 10 | Penumbra | 12.81 Bn | 12.15 Bn | 264.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -444,000.00 |
| Jun 30, 2023 | 808,000.00 |
| Mar 31, 2023 | 90,000.00 |
| Dec 31, 2022 | 2.00 Mn |
| Sep 30, 2022 | -2.36 Mn |
| Jun 30, 2022 | -956,000.00 |
| Mar 31, 2022 | -1.01 Mn |
| Dec 31, 2021 | -918,000.00 |
| Sep 30, 2021 | -1.14 Mn |
| Jun 30, 2021 | -408,000.00 |
| Mar 31, 2021 | -1.48 Mn |
| Dec 31, 2020 | 787,000.00 |
| Sep 30, 2020 | 14,000.00 |
| Jun 30, 2020 | 511,000.00 |
| Mar 31, 2020 | -1.66 Mn |
| Dec 31, 2019 | 592,000.00 |
| Sep 30, 2019 | -772,000.00 |
| Jun 30, 2019 | -71,000.00 |
| Mar 31, 2019 | 24,000.00 |
| Dec 31, 2018 | -44,000.00 |